Companies / Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

Nasdaq: TRDACIK 1689375BOSTON, MA

Financials · FY2025

Revenue$25.42M
Net income$-143.75M
Total debt—
Cash$99.28M
Diluted EPS$-3.47
Shares outstanding38.9M

Ownership

38.9M shares outstanding · as of Jul 31, 2026
2.8%Insiders
Ownership
Insiders2.80%1,088,336
Institutions68.81%26,793,477
Public float28.39%11,054,856

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Doshi DipalCEOCEO · Director
1.35%526,014
Sethuraman NatarajanPresident, Research & Develop.
0.62%242,224
Dowden Nathan JPresident & COO
0.51%198,588
Wentworth Kory JamesChief Financial Officer
0.31%121,510
Kim Peter SDirector
——
Thistle MaryDirector
——

Institutional holders 116

View all →
HolderValue% of shares
Baker Bros. Advisors LP$64.02M13.03%
5AM Venture Management, LLC$41.70M10.42%
TCG Crossover Management, LLC$21.47M5.36%
BlackRock, Inc.$19.01M6.63%
Vanguard Group Inc$16.78M4.19%
Merck & Co., Inc.$12.80M4.47%
Wellington Management Group LLP$10.74M2.68%
Geode Capital Management, LLC$8.42M1.71%
StepStone Group LP$7.83M1.96%
Millennium Management LLC$6.55M1.33%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 3, 2026Doshi Dipal
CEO
OtherCommon Stock$225.5K-19K
-3.52%
526,014
1.35% of shares
low
Mar 3, 2026Dowden Nathan J
Executive
OtherCommon Stock$165.0K-14K
-6.17%
213,598
0.55% of shares
low
Mar 10, 2026Dowden Nathan J
Executive
SellCommon Stock$155.2K-12K
-5.65%
198,588
0.51% of shares
medium
Mar 10, 2026Wentworth Kory James
Executive
SellCommon Stock$148.2K-11K
-8.57%
121,510
0.31% of shares
medium
Mar 2, 2026Doshi Dipal
CEO
OtherCommon Stock$115.1K-10K
-1.78%
545,195
1.40% of shares
low
Mar 4, 2026Wentworth Kory James
Executive
SellCommon Stock$97.9K-8K
-5.47%
137,987
0.35% of shares
low
Mar 3, 2026Sethuraman Natarajan
Executive
OtherCommon Stock$89.1K-8K
-3.03%
242,224
0.62% of shares
low
Mar 2, 2026Dowden Nathan J
Executive
OtherCommon Stock$84.2K-7K
-3.08%
227,636
0.58% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TRDACommon StockEquity29384C108BBG00MTSMC16